Coronavirus Notebook: BARDA Contracting Scrutiny; Part D Cost Sharing
Dispatches from a world turned upside down covering a possible US government investigation into BARDA contracting practices and Medicare Part D plans waiving cost sharing for COVID-19 treatments.
You may also be interested in...
Countries naturally want their citizens to have access to any COVID-19 vaccines once they are developed and approved. The European Commission has asked the EU member states for a mandate to negotiate advance contracts on their behalf with pharmaceutical firms, but some are worried the initiative lacks transparency and could lead to unhealthy competition for access at the global level.
Request for documents and a briefing is part of efforts to ensure federal programs are ‘protected from price gouging.’
More than 40 Phase III trials are assessing pre- and post-exposure prophylaxis of SARS-CoV-2 infection.